The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Eva Boratto Biography and Net Worth

Former CFO of CVS Health

Ms. Boratto served as Executive Vice President and Chief Financial Officer of CVS Health and was responsible for all aspects of the Company’s financial strategy and operations, including accounting and financial reporting, investor relations, mergers and acquisitions, treasury and capital planning, investments, risk management, tax, budgeting and planning, and procurement. Ms. Boratto has an extensive financial background that spans more than 20 years and includes senior positions in both the pharmaceutical manufacturing and pharmacy benefit management (“PBM”) industries, along with other health care finance roles. Provided by Tagnifi.

What is Eva C. Boratto's net worth?: The estimated net worth of Eva C. Boratto is at least $94,052.00 as of February 2nd, 2024. Ms. Boratto owns 1,400 shares of CVS Health stock worth more than $94,052 as of April 26th. This net worth approximation does not reflect any other assets that Ms. Boratto may own. Learn More about Eva C. Boratto's net worth.
How do I contact Eva C. Boratto?: The corporate mailing address for Ms. Boratto and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Eva C. Boratto's contact information.
Has Eva C. Boratto been buying or selling shares of CVS Health?: Eva C. Boratto has not been actively trading shares of CVS Health within the last three months. Most recently, Eva C. Boratto sold 4,905 shares of the business's stock in a transaction on Tuesday, May 4th. The shares were sold at an average price of $80.00, for a transaction totalling $392,400.00. Following the completion of the sale, the chief financial officer now directly owns 115,331 shares of the company's stock, valued at $9,226,480. Learn More on Eva C. Boratto's trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 2 times. They purchased a total of 16,000 shares worth more than $1,117,440.00. In the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 55,232 shares worth more than $4,197,811.63. The most recent insider tranaction occured on February, 16th when EVP Prem S Shah sold 29,473 shares worth more than $2,267,947.35. Insiders at CVS Health own 0.2% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 2/16/2024.

Eva C. Boratto Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/4/2021	Sell	4,905	$80.00	$392,400.00	115,331
3/16/2021	Sell	18,882	$74.68	$1,410,107.76
9/12/2019	Sell	8,130	$65.00	$528,450.00	55,273
9/17/2018	Sell	13,311	$77.16	$1,027,076.76	55,162
3/17/2017	Sell	6,029	$79.60	$479,908.40	41,614
7/20/2015	Sell	22,107	$110.34	$2,439,286.38
7/21/2014	Sell	22,107	$76.77	$1,697,154.39
10/18/2013	Sell	11,053	$60.50	$668,706.50

Eva C. Boratto Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $67.18

$66.75

$67.42

50 Day Range

MA: $74.42

$67.18

$79.76

2 Week Range

Now: $67.18

$64.41

$83.25

Volume

6,393,752 shs

Average Volume

10,655,146 shs

Market Capitalization

$84.68 billion

P/E Ratio

10.40

Dividend Yield

3.92%

Beta

0.52

Move Your Money Before May 22

From Stansberry Research | Ad